PAX5 expression in rhabdomyosarcoma

American Journal of Surgical Pathology

Volumn 33, Issue 10, 2009, Pages 1575-1577

  Morgenstern, Daniel A ^a   Gibson, Sian ^b   Sebire, Neil J ^b   Anderson, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; MONOCLONAL ANTIBODY; PARAFFIN; PHOSPHATE BUFFERED SALINE; TRANSCRIPTION FACTOR PAX5;

ADOLESCENT; CHILD; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE MUTATION; GENE TRANSLOCATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; KARYOTYPING; LETTER; MALE; MOLECULAR GENETICS; NEWBORN; PRESCHOOL CHILD; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SCHOOL CHILD;

B-CELL-SPECIFIC ACTIVATOR PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; PAIRED BOX TRANSCRIPTION FACTORS; PAX7 TRANSCRIPTION FACTOR; RHABDOMYOSARCOMA, ALVEOLAR; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 70349653067     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181abe137     Document Type: Letter

References (4)

1. Folpe AL, McKenney JK, Bridge JA, et al. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinized matrixrich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma or angiosarcoma. Am J Surg Pathol. 2002;26:1175-1183.
2. Souabni A, Jochum W, Busslinger M. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus. Blood. 2007;109:281-289.
3. Sullivan LM, Atkins KA, LeGallo RD. PAX immunoreactivity identifies alveolar rhabdomyosarcoma. Am J Surg Pathol. 2009;33:775-780 [Epub ahead of print 10.1097/PAS.0b013e318191614f].
4. Yan M, Himoudi N, Pule M, et al. Development of cellular immune responses against PAX5, a novel target for cancer immunotherapy. Cancer Res. 2008;68:8058-8065.